269 related articles for article (PubMed ID: 25461773)
1. Methods for generating and applying pharmacophore models as virtual screening filters and for bioactivity profiling.
Vuorinen A; Schuster D
Methods; 2015 Jan; 71():113-34. PubMed ID: 25461773
[TBL] [Abstract][Full Text] [Related]
2. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
Zhang X; Wong SE; Lightstone FC
J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
[TBL] [Abstract][Full Text] [Related]
3. SABRE: ligand/structure-based virtual screening approach using consensus molecular-shape pattern recognition.
Wei NN; Hamza A
J Chem Inf Model; 2014 Jan; 54(1):338-46. PubMed ID: 24328054
[TBL] [Abstract][Full Text] [Related]
4. Virtual screening of cathepsin k inhibitors using docking and pharmacophore models.
Ravikumar M; Pavan S; Bairy S; Pramod AB; Sumakanth M; Kishore M; Sumithra T
Chem Biol Drug Des; 2008 Jul; 72(1):79-90. PubMed ID: 18498326
[TBL] [Abstract][Full Text] [Related]
5. Structure-Based Virtual Screening.
Li Q; Shah S
Methods Mol Biol; 2017; 1558():111-124. PubMed ID: 28150235
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a small-molecule inhibitor of STAT3 by ligand-based pharmacophore screening.
Leung KH; Liu LJ; Lin S; Lu L; Zhong HJ; Susanti D; Rao W; Wang M; Che WI; Chan DS; Leung CH; Chan PW; Ma DL
Methods; 2015 Jan; 71():38-43. PubMed ID: 25160651
[TBL] [Abstract][Full Text] [Related]
7. 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors.
Sakkiah S; Thangapandian S; John S; Kwon YJ; Lee KW
Eur J Med Chem; 2010 Jun; 45(6):2132-40. PubMed ID: 20206418
[TBL] [Abstract][Full Text] [Related]
8. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space.
Koutsoukas A; Paricharak S; Galloway WR; Spring DR; Ijzerman AP; Glen RC; Marcus D; Bender A
J Chem Inf Model; 2014 Jan; 54(1):230-42. PubMed ID: 24289493
[TBL] [Abstract][Full Text] [Related]
9. On the value of homology models for virtual screening: discovering hCXCR3 antagonists by pharmacophore-based and structure-based approaches.
Huang D; Gu Q; Ge H; Ye J; Salam NK; Hagler A; Chen H; Xu J
J Chem Inf Model; 2012 May; 52(5):1356-66. PubMed ID: 22545675
[TBL] [Abstract][Full Text] [Related]
10. Considerations in compound database preparation--"hidden" impact on virtual screening results.
Knox AJ; Meegan MJ; Carta G; Lloyd DG
J Chem Inf Model; 2005; 45(6):1908-19. PubMed ID: 16309298
[TBL] [Abstract][Full Text] [Related]
11. Flexi-pharma: a molecule-ranking strategy for virtual screening using pharmacophores from ligand-free conformational ensembles.
Lans I; Palacio-Rodríguez K; Cavasotto CN; Cossio P
J Comput Aided Mol Des; 2020 Oct; 34(10):1063-1077. PubMed ID: 32656619
[TBL] [Abstract][Full Text] [Related]
12. Novel technologies for virtual screening.
Lengauer T; Lemmen C; Rarey M; Zimmermann M
Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
[TBL] [Abstract][Full Text] [Related]
13. Molecular fingerprint similarity search in virtual screening.
Cereto-Massagué A; Ojeda MJ; Valls C; Mulero M; Garcia-Vallvé S; Pujadas G
Methods; 2015 Jan; 71():58-63. PubMed ID: 25132639
[TBL] [Abstract][Full Text] [Related]
14. De novo design based pharmacophore query generation and virtual screening for the discovery of Hsp-47 inhibitors.
Katarkar A; Haldar PK; Chaudhuri K
Biochem Biophys Res Commun; 2015 Jan; 456(3):707-13. PubMed ID: 25522881
[TBL] [Abstract][Full Text] [Related]
15. Virtual screening strategies in drug discovery.
McInnes C
Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
[TBL] [Abstract][Full Text] [Related]
16. Multi-Pharmacophore Modeling of Caspase-3 Inhibitors using Crystal, Dock and Flexible Conformation Schemes.
Kumar SP; Jha PC
Comb Chem High Throughput Screen; 2018; 21(1):26-40. PubMed ID: 29295689
[TBL] [Abstract][Full Text] [Related]
17. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
Klabunde T; Giegerich C; Evers A
J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
[TBL] [Abstract][Full Text] [Related]
18. Pharmacophore modeling and virtual screening for designing potential 5-lipoxygenase inhibitors.
Aparoy P; Kumar Reddy K; Kalangi SK; Chandramohan Reddy T; Reddanna P
Bioorg Med Chem Lett; 2010 Feb; 20(3):1013-8. PubMed ID: 20045317
[TBL] [Abstract][Full Text] [Related]
19. Multiple pharmacophore models combined with molecular docking: a reliable way for efficiently identifying novel PDE4 inhibitors with high structural diversity.
Chen Z; Tian G; Wang Z; Jiang H; Shen J; Zhu W
J Chem Inf Model; 2010 Apr; 50(4):615-25. PubMed ID: 20353193
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore-based virtual screening.
Horvath D
Methods Mol Biol; 2011; 672():261-98. PubMed ID: 20838973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
